PUB - Publikationen an der Universität Bielefeld

Mease, P. J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., Rudwaleit, M., et al. (2022). Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. In American College of Rheumatolgy (Ed.), Arthritis & Rheumatology: Vol. 74. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA (pp. 810-813). Hoboken: Wiley. https://doi.org/10.1002/art.42355

Mease, P. J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., Rudwaleit, M., De la Loge, C., Ellis, A., Fleurinck, C., et al. (2022). “Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies” in ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, American College of Rheumatolgy ed. Arthritis & Rheumatology, vol. 74, (Hoboken: Wiley), 810-813.

Mease, P.J., et al., 2022. Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. In American College of Rheumatolgy, ed. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. no.74 Hoboken: Wiley, pp. 810-813.

P.J. Mease, et al., “Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies”, ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA, American College of Rheumatolgy, ed., Arthritis & Rheumatology, vol. 74, Hoboken: Wiley, 2022, pp.810-813.

Mease, P.J., Deodhar, A., Dougados, M., Dubreuil, M., Magrey, M., Marzo-Ortega, H., Rudwaleit, M., De la Loge, C., Ellis, A., Fleurinck, C., Oortgiesen, M., Taieb, V., Gensler, L.: Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies. In: American College of Rheumatolgy (ed.) ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Arthritis & Rheumatology. 74, p. 810-813. Wiley, Hoboken (2022).

Mease, Philip J., Deodhar, Atul, Dougados, Maxime, Dubreuil, Maureen, Magrey, Marina, Marzo-Ortega, Helena, Rudwaleit, Martin, De la Loge, Christine, Ellis, Alicia, Fleurinck, Carmen, Oortgiesen, Marga, Taieb, Vanessa, and Gensler, Lianne. “Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 Studies”. ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. Ed. American College of Rheumatolgy. Hoboken: Wiley, 2022.Vol. 74. Arthritis & Rheumatology. 810-813.